Evolution of the Average Target: Axogen, Inc.

Evolution of the Average Target - Axogen, Inc.

Evolution of the Target Price: Axogen, Inc.

Evolution of the Target Price - Axogen, Inc.

Changes in Analyst Recommendations: Axogen, Inc.

9b942b0a2a68c.7IBRGJVIuieUilCbVszZFqujs83SoxYfHoCm44h_ATQ.qrMofvg6j0TRzSfTBZ2AYfrVx6fq0kd1ScjDkaU0YACZ5Wdx5BHZVf7iAQ~e5f9adcf7b0a64099258e8d98555ce9b
30/10 Truist Securities Adjusts Price Target on Axogen to $60 From $53, Keeps Buy Rating MT
12/10 BofA Securities Initiates Axogen at Buy, $52 Price Target MT
07/10 Barclays Initiates Coverage on Axogen With Overweight Rating, $55 Price Target MT
07/10 Barclays Initiates Axogen at Overweight With $55 Price Target MT
01/10 Truist Cuts Price Target on Axogen to $53 From $60, Keeps Buy Rating MT
27/08 U.S. research roundup- Intuit, MongoDB, Zscaler RE
26/08 Truist Securities Initiates Axogen at Buy With $60 Price Target MT
19/02 Wells Fargo Initiates Coverage on Axogen With Overweight Rating, $40 Price Target MT
01/12 Mizuho Securities Initiates Coverage on Axogen With Outperform Rating, $40 Price Target MT
30/09/25 HC Wainwright Initiates Axogen at Buy With $25 Price Target MT
17/03/25 Lake Street Initiates Axogen at Buy With $30 Price Target MT
01/07/24 Raymond James Initiates AxoGen at Outperform With $13 Price Target MT
12/11/22 Jefferies Assumes AxoGen at Buy With $15 Price Target MT
09/11/22 Cantor Fitzgerald Adjusts AxoGen Price Target to $18 From $20, Maintains Overweight Rating MT
10/05/22 Canaccord Genuity Upgrades AxoGen to Buy from Hold, Adjusts Price Target to $15 from $10 MT
06/05/22 SVB Leerink Adjusts AxoGen's Price Target to $14 from $12, Keeps Outperform Rating MT
05/11/21 JMP Securities Adjusts Price Target on AxoGen to $20 from $25, Keeps Market Outperform Rating MT
07/05/21 AxoGen : Canaccord Genuity Adjusts AxoGen PT to $24 From $21, Maintains Hold Rating MT
24/02/21 AxoGen : SVB Leerink Adjusts AxoGen's Price Target to $27 From $23, Keeps Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+6.64%
+9.84%
+14.21%
+19.96%
+15.37%
+9.58%
+6.68%
+4.45%
+10.25%
+23.94%
Average +12.09%
Weighted average by Cap. +12.86%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
56.35USD
Average target price
60.09USD
Spread / Average Target
+6.64%
High Price Target
65.00USD
Spread / Highest target
+15.35%
Low Price Target
56.00USD
Spread / Lowest Target
-0.62%

Analyst Consensus Detail

Analyst consensus - Axogen, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Axogen, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Axogen, Inc.
  1. Stock Market
  2. Stocks
  3. AXGN Stock
  4. Consensus Axogen, Inc.